Cardiology Research and Practice · 2019 · 10 citations · 22 references
MedicineCardiologyClinical CardiologyDiabetologyPreventive CardiologyCardiac BiomarkersCardiovascular DiseaseCardiovascular PathologyCardiovascular RiskCoronary Artery DiseaseIschemic Heart DiseaseEndogenous InhibitorsHypertension-related Cardiac RiskMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesWhole Blood Collection
Background . Arterial hypertension (HT) is a serious and prevalent epidemiological factor in the development of coronary artery disease (CAD). Metalloproteinases (MMPs), especially MMP-2 and MMP-9, and their natural endogenous tissue inhibitors (TIMPs) are involved in the pathogenesis of HT and its complications. MMPs are also involved in the development of diabetes (DM), a risk factor for CAD. The aim of the study was to explore the influence of CAD, HT, and DM on changes in plasma levels of MMP-2 and MMP-9 and their inhibitor TIMP-4. Methods and Results . The study involved 70 patients with stable CAD admitted for coronary angiography and 15 healthy subjects. Whole blood samples were collected prior to angiography. MMP-2, MMP-9, and TIMP-4 levels in plasma were estimated using ELISA tests. CAD patients showed a significantly increased level of TIMP-4 and decreased level of MMP-2 in comparison to healthy controls (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.011</mml:mn></mml:mrow></mml:math> and <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.037</mml:mn></mml:mrow></mml:math>, respectively). Concentration of MMP-2, MMP-9, and TIMP-4 did not differ in the group with and without hypertension. Patients with DM presented higher MMP-2 level than patients without DM (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mrow><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math>). Multiple regression analysis of the influence of independent variables such as CAD stage, DM, and HT on MMP-2, MMP-9, and TIMP-4 showed that only DM was independently associated with a higher level of MMP-2 ( β = 0.42, R 2 = 0.17, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mrow><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math>). Conclusion . Data showed that patients with CAD presented higher TIMP-4 and lower MMP-2 concentration regardless of HT and DM. HT had no effect on MMP-2, MMP-9, and TIMP-4 levels in serum. DM was independently associated with higher MMP-2 concentration; however, co-occurrence of CAD and DM was associated with the balance in the MMP-2 level. Concentration of MMP-9 did not change significantly in any of the analysed groups.
22
Steven M. Haffner, Seppo Lehto, Tapani Rönnemaa et al. · New England Journal of Medicine · 1998 · 7.1K citations · Full text
Yasmin Yasmin, Sharon Wallace, Carmel M. McEniery et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 498 citations · Full text
Medicine, Cardiology, Physiology +14
Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity
Shiro Uemura, Hidetsugu Matsushita, Wei Li et al. · Circulation Research · 2001 · 486 citations
Diabetes mellitus: complications and therapeutics.
Brajendra K. Tripathi, Arvind K. Srivastava · PubMed · 2006 · 394 citations
Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases
S. Hinan Ahmed, Leslie L. Clark, Weems R. Pennington et al. · Circulation · 2006 · 384 citations